These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6420434)

  • 1. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
    Braund W; Roeger DC; Judd SJ
    J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pulsatile secretion of progesterone during the human luteal phase.
    Steele PA; Braund W; Judd SJ
    Clin Reprod Fertil; 1986 Apr; 4(2):117-24. PubMed ID: 3742433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogenic modulation of the gonadotropin-releasing hormone-stimulated secretory activity of the gonadotrope and lactotrope in prepubertal females with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1202-9. PubMed ID: 1955502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
    Cetel NS; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naloxone on luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in the different phases of the estrous cycle.
    Piva F; Maggi R; Limonta P; Motta M; Martini L
    Endocrinology; 1985 Aug; 117(2):766-72. PubMed ID: 3926461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained effects of opioid antagonism during the normal human luteal phase.
    Gindoff PR; Jewelewicz R; Hembree W; Wardlaw S; Ferin M
    J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin-releasing action of a low dose of exogenous gonadotropin-releasing hormone throughout the human menstrual cycle.
    Mais V; Melis GB; Paoletti AM; Strigini F; Antinori D; Fioretti P
    Neuroendocrinology; 1986; 44(3):326-30. PubMed ID: 3100975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
    Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
    Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of the luteal phase and its transition into the follicular phase.
    Vermesh M; Kletzky OA
    J Clin Endocrinol Metab; 1987 Oct; 65(4):653-8. PubMed ID: 3116029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naloxone on GnRH-induced LH and FSH release in buffalo, Bubalus bubalis.
    Palta P; Chandrasekhar T; Prakash BS; Madan ML
    Indian J Exp Biol; 2000 Apr; 38(4):390-2. PubMed ID: 11218818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory patterns and rates of gonadotropin-releasing hormone, follicle-stimulating hormone, and luteinizing hormone revealed by intensive sampling of pituitary venous blood in the luteal phase mare.
    Irvine CH; Alexander SL
    Endocrinology; 1993 Jan; 132(1):212-8. PubMed ID: 8419124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone ontogeny in the ovine fetus. XXVII. Pulsatile and copulsatile secretion of luteinizing hormone, follicle-stimulating hormone, growth hormone, and prolactin in late gestation: a new method for the analysis of copulsatility.
    Albers N; Bettendorf M; Herrmann H; Kaplan SL; Grumbach MM
    Endocrinology; 1993 Feb; 132(2):701-9. PubMed ID: 8425489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exogenous and endogenous gonadotropin-releasing hormone on prolactin secretion in perimenopausal women.
    Cano A; Parrilla JJ; Abad L
    Gynecol Obstet Invest; 1988; 26(4):308-12. PubMed ID: 3147927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen dependence of the periovulatory plasma prolactin response to gonadotropin-releasing hormone in normal women.
    Barbarino A; De Marinis L; Mancini A; D'Amico C; Minnielli S
    Metabolism; 1983 Nov; 32(11):1059-62. PubMed ID: 6413811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.